vs
Lemonade, Inc.（LMND）与Ultragenyx Pharmaceutical Inc.（RARE）财务数据对比。点击上方公司名可切换其他公司
Lemonade, Inc.的季度营收约是Ultragenyx Pharmaceutical Inc.的1.1倍（$228.1M vs $207.3M），Lemonade, Inc.净利率更高（-9.5% vs -62.0%，领先52.5%），Lemonade, Inc.同比增速更快（53.3% vs 25.9%），Lemonade, Inc.自由现金流更多（$-25.9M vs $-100.8M），过去两年Lemonade, Inc.的营收复合增速更高（38.4% vs 38.0%）
Lemonade, Inc.是一家总部位于美国纽约的保险公司，在美国市场提供租客险、房屋险、车险、宠物险及定期寿险，在德国、荷兰推出财产及责任保险，法国市场提供租客险，当前拥有约290万用户，采用人工智能及聊天机器人替代人工处理理赔申请。
Ultragenyx Pharmaceutical Inc.是一家总部位于美国的生物制药企业，专注于研发罕见病和超罕见遗传病的创新治疗方案，这类疾病目前大多无获批疗法，存在大量未被满足的临床需求。公司覆盖生物制剂、小分子药物、基因疗法、反义寡核苷酸及mRNA等多种药物技术平台，研发管线涵盖骨骼、内分泌、代谢、肌肉及中枢神经系统疾病领域。
LMND vs RARE — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $228.1M | $207.3M |
| 净利润 | $-21.7M | $-128.6M |
| 毛利率 | — | — |
| 营业利润率 | -9.0% | -54.7% |
| 净利率 | -9.5% | -62.0% |
| 营收同比 | 53.3% | 25.9% |
| 净利润同比 | 27.7% | 3.5% |
| 每股收益（稀释后） | $-0.27 | $-1.28 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $228.1M | $207.3M | ||
| Q3 25 | $194.5M | $159.9M | ||
| Q2 25 | $164.1M | $166.5M | ||
| Q1 25 | $151.2M | $139.3M | ||
| Q4 24 | $148.8M | $164.6M | ||
| Q3 24 | $136.6M | $139.5M | ||
| Q2 24 | $122.0M | $147.0M | ||
| Q1 24 | $119.1M | $108.8M |
| Q4 25 | $-21.7M | $-128.6M | ||
| Q3 25 | $-37.5M | $-180.4M | ||
| Q2 25 | $-43.9M | $-115.0M | ||
| Q1 25 | $-62.4M | $-151.1M | ||
| Q4 24 | $-30.0M | $-133.2M | ||
| Q3 24 | $-67.7M | $-133.5M | ||
| Q2 24 | $-57.2M | $-131.6M | ||
| Q1 24 | $-47.3M | $-170.7M |
| Q4 25 | -9.0% | -54.7% | ||
| Q3 25 | -18.7% | -106.9% | ||
| Q2 25 | -26.0% | -64.8% | ||
| Q1 25 | -40.6% | -102.6% | ||
| Q4 24 | -25.4% | -74.3% | ||
| Q3 24 | -48.2% | -94.6% | ||
| Q2 24 | -45.2% | -79.1% | ||
| Q1 24 | -38.0% | -151.9% |
| Q4 25 | -9.5% | -62.0% | ||
| Q3 25 | -19.3% | -112.8% | ||
| Q2 25 | -26.8% | -69.0% | ||
| Q1 25 | -41.3% | -108.5% | ||
| Q4 24 | -20.2% | -80.9% | ||
| Q3 24 | -49.6% | -95.7% | ||
| Q2 24 | -46.9% | -89.5% | ||
| Q1 24 | -39.7% | -156.8% |
| Q4 25 | $-0.27 | $-1.28 | ||
| Q3 25 | $-0.51 | $-1.81 | ||
| Q2 25 | $-0.60 | $-1.17 | ||
| Q1 25 | $-0.86 | $-1.57 | ||
| Q4 24 | $-0.42 | $-1.34 | ||
| Q3 24 | $-0.95 | $-1.40 | ||
| Q2 24 | $-0.81 | $-1.52 | ||
| Q1 24 | $-0.67 | $-2.03 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $399.1M | $421.0M |
| 总债务越低越好 | — | — |
| 股东权益账面价值 | $533.6M | $-80.0M |
| 总资产 | $1.9B | $1.5B |
| 负债/权益比越低杠杆越低 | — | — |
8季度趋势，按日历期对齐
| Q4 25 | $399.1M | $421.0M | ||
| Q3 25 | $369.4M | $202.5M | ||
| Q2 25 | $398.8M | $176.3M | ||
| Q1 25 | $329.7M | $127.1M | ||
| Q4 24 | $403.5M | $174.0M | ||
| Q3 24 | $360.9M | $150.6M | ||
| Q2 24 | $387.2M | $480.7M | ||
| Q1 24 | $300.8M | $112.3M |
| Q4 25 | $533.6M | $-80.0M | ||
| Q3 25 | $516.2M | $9.2M | ||
| Q2 25 | $527.1M | $151.3M | ||
| Q1 25 | $545.5M | $144.2M | ||
| Q4 24 | $593.4M | $255.0M | ||
| Q3 24 | $593.0M | $346.8M | ||
| Q2 24 | $635.2M | $432.4M | ||
| Q1 24 | $676.4M | $140.3M |
| Q4 25 | $1.9B | $1.5B | ||
| Q3 25 | $1.9B | $1.2B | ||
| Q2 25 | $1.9B | $1.3B | ||
| Q1 25 | $1.9B | $1.3B | ||
| Q4 24 | $1.8B | $1.5B | ||
| Q3 24 | $1.8B | $1.5B | ||
| Q2 24 | $1.7B | $1.6B | ||
| Q1 24 | $1.6B | $1.3B |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $-16.5M | $-99.8M |
| 自由现金流经营现金流 - 资本支出 | $-25.9M | $-100.8M |
| 自由现金流率自由现金流/营收 | -11.4% | -48.6% |
| 资本支出强度资本支出/营收 | 4.1% | 0.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-69.4M | $-472.0M |
8季度趋势，按日历期对齐
| Q4 25 | $-16.5M | $-99.8M | ||
| Q3 25 | $4.5M | $-91.4M | ||
| Q2 25 | $5.5M | $-108.3M | ||
| Q1 25 | $-47.2M | $-166.5M | ||
| Q4 24 | $-11.4M | $-79.3M | ||
| Q3 24 | $16.3M | $-67.0M | ||
| Q2 24 | $-11.7M | $-77.0M | ||
| Q1 24 | $-29.8M | $-190.7M |
| Q4 25 | $-25.9M | $-100.8M | ||
| Q3 25 | $2.6M | $-92.7M | ||
| Q2 25 | $3.4M | $-110.7M | ||
| Q1 25 | $-49.5M | $-167.8M | ||
| Q4 24 | $-20.8M | $-79.5M | ||
| Q3 24 | $14.1M | $-68.6M | ||
| Q2 24 | $-13.2M | $-79.0M | ||
| Q1 24 | $-32.3M | $-193.9M |
| Q4 25 | -11.4% | -48.6% | ||
| Q3 25 | 1.3% | -58.0% | ||
| Q2 25 | 2.1% | -66.5% | ||
| Q1 25 | -32.7% | -120.5% | ||
| Q4 24 | -14.0% | -48.3% | ||
| Q3 24 | 10.3% | -49.2% | ||
| Q2 24 | -10.8% | -53.7% | ||
| Q1 24 | -27.1% | -178.2% |
| Q4 25 | 4.1% | 0.5% | ||
| Q3 25 | 1.0% | 0.8% | ||
| Q2 25 | 1.3% | 1.5% | ||
| Q1 25 | 1.5% | 1.0% | ||
| Q4 24 | 6.3% | 0.1% | ||
| Q3 24 | 1.6% | 1.2% | ||
| Q2 24 | 1.2% | 1.4% | ||
| Q1 24 | 2.1% | 3.0% |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
LMND
暂无分部数据
RARE
| Royalty | $105.6M | 51% |
| Products | $101.7M | 49% |
